| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.0M | -23.7% |
| SG&A Expense | $4.7M | -9.2% |
| Operating Income | -$10.5M | +20.0% |
| Pre-tax Income | -$10.1M | +23.7% |
| Income Tax | $0 | — |
| Net Income | -$10.1M | +23.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Inventory | $2.6M | -0.8% |
| Current Assets | $3.0M | -64.4% |
| Total Assets | $6.8M | -27.2% |
| Current Liabilities | $903K | -47.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $1.1M | -47.1% |
| Stockholders' Equity | $5.7M | -21.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +25.2% |
| Capital Expenditures | $34K | -83.3% |
| Investing Cash Flow | -$25K | +87.8% |
| Financing Cash Flow | $7.5M | -10.5% |
| Free Cash Flow | -$9.6M | +26.1% |